Cargando…
MicroRNAs Modulate Drug Resistance-Related Mechanisms in Hepatocellular Carcinoma
Primary liver cancer [hepatocellular carcinoma (HCC)] is one of the most common malignant tumors worldwide, causing serious health threats because of its high morbidity and mortality, rapid growth, and strong invasiveness. Patients with HCC frequently develop resistance to the current chemotherapeut...
Autores principales: | Liang, Yuehui, Liang, Qi, Qiao, Liang, Xiao, Fang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7338562/ https://www.ncbi.nlm.nih.gov/pubmed/32695666 http://dx.doi.org/10.3389/fonc.2020.00920 |
Ejemplares similares
-
Role of exosomal microRNAs in cancer therapy and drug resistance mechanisms: focus on hepatocellular carcinoma
por: Zelli, Veronica, et al.
Publicado: (2022) -
The “Macro” World of microRNAs in Hepatocellular Carcinoma
por: Sidhu, Kaveri, et al.
Publicado: (2015) -
The Key Role of microRNAs in Initiation and Progression of Hepatocellular Carcinoma
por: Khan, Suliman, et al.
Publicado: (2022) -
Mechanisms of Action And Clinical Implications of MicroRNAs in the Drug Resistance of Gastric Cancer
por: Liu, Ying, et al.
Publicado: (2021) -
The Role of MicroRNAs in Hepatocellular Carcinoma
por: Xu, Xin, et al.
Publicado: (2018)